Exicure Inc. (XCUR)
NASDAQ: XCUR
· Real-Time Price · USD
8.51
-0.48 (-5.34%)
At close: Jun 13, 2025, 3:59 PM
8.51
0.00%
After-hours: Jun 13, 2025, 04:04 PM EDT
-5.34% (1D)
| Bid | 8.5 |
| Market Cap | 53.76M |
| Revenue (ttm) | 500K |
| Net Income (ttm) | -9.7M |
| EPS (ttm) | -4.71 |
| PE Ratio (ttm) | -1.81 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 10.8 |
| Volume | 2,807 |
| Avg. Volume (20D) | 18,068 |
| Open | 8.72 |
| Previous Close | 8.99 |
| Day's Range | 8.50 - 8.83 |
| 52-Week Range | 1.44 - 36.00 |
| Beta | 3.73 |
About XCUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XCUR
Website n/a
4 months ago
-15.07%
Exicure shares are trading higher after the compan...
Unlock content with
Pro Subscription
6 months ago
+35.86%
Exicure shares are trading higher after the company reported a year-over-year increase in Q3 PES results. Additionally, the company announced it entered into a purchase agreement for $1.3 million and $8.7 million in equity financing.
2 months ago · businesswire.com
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML).
